Research Archive — Page 169 of 194
-
March 28, 2013
Acetaminophen: protective in sepsis?
In critically ill patients with sepsis, plasma hemoglobin may be a new indicator of disease severity – and a potential target for treatment with acetaminophen. -
March 23, 2013
Humanoid robot helps train children with autism
An interdisciplinary team of mechanical engineers and autism experts at Vanderbilt University have developed an adaptive robotic system and used it to demonstrate that humanoid robots can be powerful tools for enhancing the basic social learning skills of children with autism. -
March 21, 2013
Novel push-pull action clue to brain disorders
Researchers at Vanderbilt University have discovered a new “push-pull” mechanism in the brain that one day could lead to new treatments for movement disorders such as Parkinson’s disease, as well as stress-related disorders and addiction. -
March 21, 2013
Breast cancer study explores therapy to slow recurrence
Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer. -
March 20, 2013
New drugs a good BET for brain cancer
A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors. -
March 18, 2013
IRF6 on the tip of tongue development
The factor IRF6 plays important roles in the development of the tongue. -
March 15, 2013
Diagnostic codes identify smoking status
Diagnostic codes used for billing purposes effectively identify smokers in a general clinic population and can be used to adjust smoking status in genetic and epidemiologic studies.